US Patent 11576934 Methods and compositions for immunomodulation
Patent 11576934 was granted and assigned to Rubius Therapeutics on February, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11576934 Methods and compositions for immunomodulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.